'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line… | HappeningNow.news

Health · 6 views

'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment

(MedPage Today) -- The first-in-class RAS inhibitor daraxonrasib (Rasonque) in combination with chemotherapy showed promise as a first-line treatment for patients with metastatic pancreatic adenocarcinoma (PDAC), according to results from…

Source Summary Published 2h 28m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 6 Community interest
Brief read Under 1 min brief 32 words

Summary

(MedPage Today) -- The first-in-class RAS inhibitor daraxonrasib (Rasonque) in combination with chemotherapy showed promise as a first-line treatment for patients with metastatic pancreatic adenocarcinoma (PDAC), according to results from an early

Read original at MedPage Today

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page